| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-417-46 | 62135-417 | HUMAN PRESCRIPTION DRUG | doxycycline | doxycycline | POWDER, FOR SUSPENSION | ORAL | 20180101 | N/A | ANDA | ANDA065454 | Chartwell RX LLC | DOXYCYCLINE | 25 mg/5mL | 60 mL in 1 BOTTLE, GLASS (62135-417-46) |
| 62135-877-46 | 62135-877 | HUMAN PRESCRIPTION DRUG | doxycycline | doxycycline | POWDER, FOR SUSPENSION | ORAL | 20240327 | N/A | ANDA | ANDA065454 | Chartwell RX LLC | DOXYCYCLINE | 25 mg/5mL | 60 mL in 1 BOTTLE, GLASS (62135-877-46) |
| 68999-417-46 | 68999-417 | HUMAN PRESCRIPTION DRUG | doxycycline | doxycycline | POWDER, FOR SUSPENSION | ORAL | 20210901 | N/A | ANDA | ANDA065454 | Chartwell Governmental & Specialty RX, LLC | DOXYCYCLINE | 25 mg/5mL | 60 mL in 1 BOTTLE, GLASS (68999-417-46) |